BioLargo, Inc.
BLGO
$0.2576
$0.0083.21%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.09% | 55.25% | 66.79% | -65.99% | 33.06% |
| Total Depreciation and Amortization | -23.86% | -10.53% | -30.23% | 172.73% | 417.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -76.57% | -140.90% | 70.59% | 2.78% | 20.10% |
| Change in Net Operating Assets | -313.24% | -373.13% | 107.48% | 883.56% | -184.91% |
| Cash from Operations | -95,700.00% | -93.78% | 89.82% | 1,218.60% | -104.88% |
| Capital Expenditure | 117.12% | 80.98% | -353.16% | -1,697.92% | -36.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 60.96% | 80.98% | -353.16% | -1,697.92% | -36.45% |
| Total Debt Issued | 1,229.23% | -- | -- | -- | -35.00% |
| Total Debt Repaid | -103.64% | 66.67% | 40.00% | 92.31% | 2,850.00% |
| Issuance of Common Stock | -- | 232.47% | 21.60% | -19.41% | 55.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,628.57% | -- | -- | -- | -72.00% |
| Cash from Financing | 109.20% | 50.69% | -46.89% | -28.28% | 24.14% |
| Foreign Exchange rate Adjustments | 140.52% | 1,100.00% | -771.43% | 1,700.00% | -422.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.20% | -65.67% | 37.94% | -43.60% | -14.75% |